Literature DB >> 19046351

The transcription factor ATF5: role in neurodevelopment and neural tumors.

Lloyd A Greene1, Hae Young Lee, James M Angelastro.   

Abstract

We review recent findings regarding the properties of ATF5 and the major roles that this transcription factor plays in development of the nervous system and in survival of neural tumors. ATF5 is a widely expressed basic leucine zipper protein that has been subject to limited characterization. It is highly expressed in zones of neuroprogenitor cell proliferation. In vitro and in vivo studies indicate that it functions there to promote neuroprogenitor cell expansion and to suppress their differentiation into neurons or glia. ATF5 expression is down-regulated by trophic factors and this is required for their capacity to promote neuroprogenitor cell cycle exit and differentiation into either neurons, oligodendroglia or astrocytes. ATF5 is also highly expressed in a number of tumor types, including neural tumors such as neuroblastomas, medulloblastomas and glioblastomas. Examination of the role of ATF5 in glioblastoma cells indicates that interference with its expression or activity causes them to undergo apoptotic death. In contrast, normal astrocytes and neurons do not appear to require ATF5 for survival, indicating that it may be a selective target for treatment of glioblastomas and other neural neoplasias. Further studies are needed to identify the transcriptional targets of ATF5 and the mechanisms by which its expression is regulated in neuroprogenitors and tumors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19046351      PMCID: PMC2680418          DOI: 10.1111/j.1471-4159.2008.05749.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  48 in total

1.  The GABAB receptor interacts directly with the related transcription factors CREB2 and ATFx.

Authors:  J H White; R A McIllhinney; A Wise; F Ciruela; W Y Chan; P C Emson; A Billinton; F H Marshall
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

2.  Identification of diverse nerve growth factor-regulated genes by serial analysis of gene expression (SAGE) profiling.

Authors:  J M Angelastro; L Klimaschewski; S Tang; O V Vitolo; T A Weissman; L T Donlin; M L Shelanski; L A Greene
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

Review 3.  Neural stem cells: balancing self-renewal with differentiation.

Authors:  Chris Q Doe
Journal:  Development       Date:  2008-03-20       Impact factor: 6.868

4.  A hierarchical network controls protein translation during murine embryonic stem cell self-renewal and differentiation.

Authors:  Prabha Sampath; David K Pritchard; Lil Pabon; Hans Reinecke; Stephen M Schwartz; David R Morris; Charles E Murry
Journal:  Cell Stem Cell       Date:  2008-05-08       Impact factor: 24.633

5.  Cdc34-mediated degradation of ATF5 is blocked by cisplatin.

Authors:  Yuanyan Wei; Jianhai Jiang; Dan Liu; Jin Zhou; Xiaoning Chen; Si Zhang; Hongliang Zong; Xiaojing Yun; Jianxin Gu
Journal:  J Biol Chem       Date:  2008-05-05       Impact factor: 5.157

Review 6.  Developmental signaling pathways in brain tumor-derived stem-like cells.

Authors:  Paul A Clark; Daniel M Treisman; Johnathan Ebben; John S Kuo
Journal:  Dev Dyn       Date:  2007-12       Impact factor: 3.780

Review 7.  Olfactory epithelium progenitors: insights from transgenic mice and in vitro biology.

Authors:  Barbara Murdoch; A Jane Roskams
Journal:  J Mol Histol       Date:  2007-09-13       Impact factor: 2.611

8.  ATF5 is a highly abundant liver-enriched transcription factor that cooperates with constitutive androstane receptor in the transactivation of CYP2B6: implications in hepatic stress responses.

Authors:  Maya Pascual; M José Gómez-Lechón; José V Castell; Ramiro Jover
Journal:  Drug Metab Dispos       Date:  2008-03-10       Impact factor: 3.922

9.  Phosphorylation of eIF2 directs ATF5 translational control in response to diverse stress conditions.

Authors:  Donghui Zhou; L Reddy Palam; Li Jiang; Jana Narasimhan; Kirk A Staschke; Ronald C Wek
Journal:  J Biol Chem       Date:  2008-01-14       Impact factor: 5.157

10.  ATF4 is an oxidative stress-inducible, prodeath transcription factor in neurons in vitro and in vivo.

Authors:  Philipp S Lange; Juan C Chavez; John T Pinto; Giovanni Coppola; Chiao-Wang Sun; Tim M Townes; Daniel H Geschwind; Rajiv R Ratan
Journal:  J Exp Med       Date:  2008-05-05       Impact factor: 14.307

View more
  42 in total

1.  Targeting ATF5 in Cancer.

Authors:  James M Angelastro
Journal:  Trends Cancer       Date:  2017-06-13

Review 2.  The transcription factor network associated with the amino acid response in mammalian cells.

Authors:  Michael S Kilberg; Mukundh Balasubramanian; Lingchen Fu; Jixiu Shan
Journal:  Adv Nutr       Date:  2012-05-01       Impact factor: 8.701

Review 3.  Mitochondrial dysfunction in cancer: Potential roles of ATF5 and the mitochondrial UPR.

Authors:  Pan Deng; Cole M Haynes
Journal:  Semin Cancer Biol       Date:  2017-05-10       Impact factor: 15.707

4.  miR-141-3p functions as a tumor suppressor modulating activating transcription factor 5 in glioma.

Authors:  Mengyuan Wang; Ming Hu; Zhaohua Li; Dongmeng Qian; Bin Wang; David X Liu
Journal:  Biochem Biophys Res Commun       Date:  2017-06-07       Impact factor: 3.575

5.  IMPACT is a developmentally regulated protein in neurons that opposes the eukaryotic initiation factor 2α kinase GCN2 in the modulation of neurite outgrowth.

Authors:  Martín Roffé; Glaucia N M Hajj; Hátylas F Azevedo; Viviane S Alves; Beatriz A Castilho
Journal:  J Biol Chem       Date:  2013-02-27       Impact factor: 5.157

6.  Expression patterns of activating transcription factor 5 (atf5a and atf5b) in zebrafish.

Authors:  Roberto Rodríguez-Morales; Viveca Vélez-Negrón; Aranza Torrado-Tapias; Gaurav Varshney; Martine Behra
Journal:  Gene Expr Patterns       Date:  2020-07-11       Impact factor: 1.224

7.  Expression and targeting of transcription factor ATF5 in dog gliomas.

Authors:  D York; C D Sproul; N Chikere; P J Dickinson; J M Angelastro
Journal:  Vet Comp Oncol       Date:  2017-05-08       Impact factor: 2.613

8.  p300-dependent acetylation of activating transcription factor 5 enhances C/EBPβ transactivation of C/EBPα during 3T3-L1 differentiation.

Authors:  Yue Zhao; Ya-Dong Zhang; You-You Zhang; Shu-Wen Qian; Zhi-Chun Zhang; Shu-Fen Li; Liang Guo; Yuan Liu; Bo Wen; Qun-Ying Lei; Qi-Qun Tang; Xi Li
Journal:  Mol Cell Biol       Date:  2013-11-11       Impact factor: 4.272

9.  A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications.

Authors:  Zhi Sheng; Li Li; Lihua J Zhu; Thomas W Smith; Andrea Demers; Alonzo H Ross; Richard P Moser; Michael R Green
Journal:  Nat Med       Date:  2010-05-23       Impact factor: 53.440

10.  New insight on FGFR3-related chondrodysplasias molecular physiopathology revealed by human chondrocyte gene expression profiling.

Authors:  Laurent Schibler; Linda Gibbs; Catherine Benoist-Lasselin; Charles Decraene; Jelena Martinovic; Philippe Loget; Anne-Lise Delezoide; Marie Gonzales; Arnold Munnich; Jean-Philippe Jais; Laurence Legeai-Mallet
Journal:  PLoS One       Date:  2009-10-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.